2023 Q3 Form 10-Q Financial Statement

#000113709123000011 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $115.9M $121.9M
YoY Change -7.22% 1.15%
Cost Of Revenue $87.98M $94.91M
YoY Change -12.71% -7.09%
Gross Profit $27.91M $26.95M
YoY Change 15.75% 47.12%
Gross Profit Margin 24.08% 22.12%
Selling, General & Admin $10.60M $10.55M
YoY Change -8.15% 5.55%
% of Gross Profit 37.99% 39.14%
Research & Development $4.762M $4.662M
YoY Change -1.18% 2.37%
% of Gross Profit 17.07% 17.3%
Depreciation & Amortization $1.390M $1.402M
YoY Change -16.52% -18.39%
% of Gross Profit 4.98% 5.2%
Operating Expenses $15.79M $15.65M
YoY Change -6.47% 3.77%
Operating Profit $12.11M $11.31M
YoY Change 67.71% 248.81%
Interest Expense $4.164M $4.645M
YoY Change 15.19% 73.97%
% of Operating Profit 34.38% 41.09%
Other Income/Expense, Net
YoY Change
Pretax Income $7.948M $6.660M
YoY Change 120.35% 1066.37%
Income Tax $153.0K $243.0K
% Of Pretax Income 1.93% 3.65%
Net Earnings $7.795M $6.417M
YoY Change 144.2% 372.53%
Net Earnings / Revenue 6.73% 5.27%
Basic Earnings Per Share $0.34 $0.28
Diluted Earnings Per Share $0.34 $0.28
COMMON SHARES
Basic Shares Outstanding 22.97M shares 22.95M shares
Diluted Shares Outstanding 22.97M shares 22.97M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.80M $27.78M
YoY Change 93.0% 705.74%
Cash & Equivalents $31.80M $27.80M
Short-Term Investments
Other Short-Term Assets $12.50M $11.03M
YoY Change -31.76% -26.15%
Inventory $94.39M $113.2M
Prepaid Expenses
Receivables $71.42M $78.20M
Other Receivables $500.0K $555.0K
Total Short-Term Assets $226.3M $242.1M
YoY Change -8.88% 0.14%
LONG-TERM ASSETS
Property, Plant & Equipment $41.80M $38.82M
YoY Change 66.33% 44.83%
Goodwill $29.80M $29.80M
YoY Change 0.0% 0.0%
Intangibles $4.350M $4.787M
YoY Change -29.68% -28.68%
Long-Term Investments
YoY Change
Other Assets $3.186M $2.020M
YoY Change -75.04% -85.24%
Total Long-Term Assets $79.14M $75.46M
YoY Change 25.28% 15.63%
TOTAL ASSETS
Total Short-Term Assets $226.3M $242.1M
Total Long-Term Assets $79.14M $75.46M
Total Assets $305.5M $317.6M
YoY Change -1.96% 3.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.52M $71.70M
YoY Change 3.28% -5.51%
Accrued Expenses $35.10M $31.52M
YoY Change -8.3% -11.65%
Deferred Revenue $2.522M $2.399M
YoY Change 54.72% 51.26%
Short-Term Debt $159.8M $189.8M
YoY Change -24.26% -9.53%
Long-Term Debt Due $136.0K $134.0K
YoY Change -37.33% -33.0%
Total Short-Term Liabilities $276.3M $297.9M
YoY Change -15.51% -8.31%
LONG-TERM LIABILITIES
Long-Term Debt $126.0K $160.0K
YoY Change -72.31% -70.15%
Other Long-Term Liabilities $11.37M $12.04M
YoY Change -41.61% -40.46%
Total Long-Term Liabilities $11.50M $12.20M
YoY Change -42.31% -41.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $276.3M $297.9M
Total Long-Term Liabilities $11.50M $12.20M
Total Liabilities $317.8M $337.7M
YoY Change -9.55% -3.53%
SHAREHOLDERS EQUITY
Retained Earnings -$169.2M -$177.0M
YoY Change -13.88% -11.35%
Common Stock $23.00K $23.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.30M -$20.13M
YoY Change
Total Liabilities & Shareholders Equity $305.5M $317.6M
YoY Change -1.96% 3.43%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $7.795M $6.417M
YoY Change 144.2% 372.53%
Depreciation, Depletion And Amortization $1.390M $1.402M
YoY Change -16.52% -18.39%
Cash From Operating Activities $35.55M $21.57M
YoY Change 184.72% -268.33%
INVESTING ACTIVITIES
Capital Expenditures $1.430M $642.0K
YoY Change -396.07% -263.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.430M -$642.0K
YoY Change 196.07% 63.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.06M -20.05M
YoY Change -2734.53% -236.56%
NET CHANGE
Cash From Operating Activities 35.55M 21.57M
Cash From Investing Activities -1.430M -642.0K
Cash From Financing Activities -30.06M -20.05M
Net Change In Cash 4.060M 886.0K
YoY Change -69.11% -39.77%
FREE CASH FLOW
Cash From Operating Activities $35.55M $21.57M
Capital Expenditures $1.430M $642.0K
Free Cash Flow $34.12M $20.93M
YoY Change 163.09% -268.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Gross Profit
GrossProfit
18321000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23117000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22953000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
23000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157831000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176955000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
164000 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1024000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20125000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
317587000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120479000 usd
CY2023Q2 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
600000 usd
CY2022Q2 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
69000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94911000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
102158000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
26954000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4662000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4554000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
437000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
531000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
15649000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
15080000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11305000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3241000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
4645000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
2670000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6660000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
571000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
243000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-787000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
6417000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1358000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22952000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22927000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22966000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22940000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-26579000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
6417000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20125000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-44419000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1358000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-43013000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-30372000 usd
us-gaap Net Income Loss
NetIncomeLoss
10141000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-20125000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-42023000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1241000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
253000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-43013000 usd
us-gaap Net Income Loss
NetIncomeLoss
10141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1241000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
873000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1072000 usd
us-gaap Depreciation
Depreciation
1975000 usd
us-gaap Depreciation
Depreciation
2393000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
106000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
253000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
694000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1283000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
87000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-225000 usd
psix Increase Decrease In Allowance For Obsolescence
IncreaseDecreaseInAllowanceForObsolescence
1798000 usd
psix Increase Decrease In Allowance For Obsolescence
IncreaseDecreaseInAllowanceForObsolescence
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-6000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
482000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11697000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21706000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5547000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11048000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-510000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1600000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5433000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-17406000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1754000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25038000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4175000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
339000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8721000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26574000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30193000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
1254000 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
508000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1254000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-508000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
20100000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
165000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
29820000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
594000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
984000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1786000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21678000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27867000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3642000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2834000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27900000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9732000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31542000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6898000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27782000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3448000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
3760000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
3450000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31542000 usd
CY2023Q2 psix Number Of Board Members
NumberOfBoardMembers
4 boardmember
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
190300000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
211000000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions include the valuation of allowances for uncollectible receivables, inventory reserves, warranty reserves, stock-based compensation, evaluation of goodwill, other intangibles, property, plant and equipment for impairment, and determination of useful lives of long-lived assets. Actual results could materially differ from those estimates.
CY2023Q2 psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
4700000 usd
CY2022Q2 psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
4500000 usd
psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
9300000 usd
psix Research And Development Expense Excluding Engineering
ResearchAndDevelopmentExpenseExcludingEngineering
9100000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
92363000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
101566000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1516000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3073000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3491000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4170000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
5662000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
115000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19825000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
118917000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
124464000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5702000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3904000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
113215000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
120560000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3904000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3370000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2179000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
163000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
381000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
592000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5702000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2941000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
12100000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
13037000 usd
CY2023Q2 us-gaap Litigation Reserve
LitigationReserve
2202000 usd
CY2022Q4 us-gaap Litigation Reserve
LitigationReserve
2102000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2399000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2256000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
6186000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
7299000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
6692000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5257000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3790000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4158000 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
33369000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
34109000 usd
CY2023Q2 psix Standard Product Warranty Accrual Specific Warranty Related Matter
StandardProductWarrantyAccrualSpecificWarrantyRelatedMatter
1200000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
21550000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
32947000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8477000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
11442000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
22226000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25790000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
12100000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
15682000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
10126000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
10108000 usd
psix Product Warranty Expense Net Of Recoveries
ProductWarrantyExpenseNetOfRecoveries
8500000 usd
psix Product Warranty Expense Net Of Recoveries
ProductWarrantyExpenseNetOfRecoveries
1900000 usd
psix Product Warranty Recoveries
ProductWarrantyRecoveries
-700000 usd
psix Product Warranty Recoveries
ProductWarrantyRecoveries
-2100000 usd
psix Standard Product Warranty Accrual Earnings Per Share Diluted
StandardProductWarrantyAccrualEarningsPerShareDiluted
0.25
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
100000 usd
psix Standard Product Warranty Accrual Earnings Per Share Diluted
StandardProductWarrantyAccrualEarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121865000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120479000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238334000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121865000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120479000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238334000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5300000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
2173000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
1629000 usd
us-gaap Lease Cost
LeaseCost
4175000 usd
CY2023Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
11342000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
3620000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2399000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2256000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2836000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3199000 usd
CY2023Q2 psix Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
6107000 usd
CY2022Q4 psix Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1835000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
600000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000.0 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
500000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100000 usd
CY2023Q2 psix Debt Instrument Number Of Loan Agreements
DebtInstrumentNumberOfLoanAgreements
4 agreement
CY2023Q1 psix Collaborative Arrangement Term
CollaborativeArrangementTerm
P3Y
CY2023Q2 psix Collaborative Arrangement Sales
CollaborativeArrangementSales
1000000 usd
psix Collaborative Arrangement Sales
CollaborativeArrangementSales
2100000 usd
CY2022Q2 psix Collaborative Arrangement Sales
CollaborativeArrangementSales
100000 usd
psix Collaborative Arrangement Sales
CollaborativeArrangementSales
500000 usd
CY2023Q2 psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
700000 usd
psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
3800000 usd
CY2022Q2 psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
2900000 usd
psix Collaborative Arrangement Inventory Purchased Goods
CollaborativeArrangementInventoryPurchasedGoods
7100000 usd
CY2023Q2 psix Collaborative Arrangement Outstanding Receivables
CollaborativeArrangementOutstandingReceivables
2000000 usd
CY2022Q4 psix Collaborative Arrangement Outstanding Receivables
CollaborativeArrangementOutstandingReceivables
2300000 usd
CY2023Q2 psix Collaborative Arrangement Accounts Payable
CollaborativeArrangementAccountsPayable
24400000 usd
CY2022Q4 psix Collaborative Arrangement Accounts Payable
CollaborativeArrangementAccountsPayable
23400000 usd
us-gaap Lease Cost
LeaseCost
3364000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1448000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1160000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2807000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2339000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
20000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
40000 usd
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
55167000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
53321000 usd
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
41351000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
39477000 usd
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13816000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13844000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
29800000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
29800000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37340000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32553000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4787000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37340000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31680000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5660000 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
189820000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
205614000 usd
CY2023Q2 psix Finance Lease Liability And Other Long Term Debt
FinanceLeaseLiabilityAndOtherLongTermDebt
515000 usd
CY2022Q4 psix Finance Lease Liability And Other Long Term Debt
FinanceLeaseLiabilityAndOtherLongTermDebt
619000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
515000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5419000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
219000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
220000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
296000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5199000 usd
CY2023Q1 psix Number Of Shareholder Loan Agreements Amended
NumberOfShareholderLoanAgreementsAmended
2 agreement
CY2023Q1 psix Number Of Shareholder Loan Agreements
NumberOfShareholderLoanAgreements
4 agreement
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
190300000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27800000 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6700000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
41000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
88000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
8000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
12000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
258000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
401000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
65000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
442000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
340000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
918000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
720000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
264000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
271000 usd
us-gaap Sublease Income
SubleaseIncome
530000 usd
us-gaap Sublease Income
SubleaseIncome
536000 usd
CY2023Q2 psix Lease Cost Excluding Sublease Income
LeaseCostExcludingSubleaseIncome
1908000 usd
CY2022Q2 psix Lease Cost Excluding Sublease Income
LeaseCostExcludingSubleaseIncome
1303000 usd
psix Lease Cost Excluding Sublease Income
LeaseCostExcludingSubleaseIncome
3645000 usd
psix Lease Cost Excluding Sublease Income
LeaseCostExcludingSubleaseIncome
2688000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2426000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2424000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
8000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
44000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
93000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13986000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.065
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.066
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25005000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13282000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2753000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2894000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23316000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10971000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
26069000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13865000 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
184000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
225000 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
85000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
90000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
136000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
170000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
221000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
260000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2183000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
57000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5214000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
84000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5376000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
81000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5126000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
17000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5209000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4205000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6059000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33372000 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
239000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7303000 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
18000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
26069000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
221000 usd
psix Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
5 letterofcredit
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2100000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
3800000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.036
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.036
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.378
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
6417000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1358000 usd
us-gaap Net Income Loss
NetIncomeLoss
10141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1241000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22952000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22927000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22952000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22927000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22966000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22940000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22967000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22927000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001137091-23-000011-index-headers.html Edgar Link pending
0001137091-23-000011-index.html Edgar Link pending
0001137091-23-000011.txt Edgar Link pending
0001137091-23-000011-xbrl.zip Edgar Link pending
exhibit311-ceocertificatio.htm Edgar Link pending
exhibit312-cfocertificatio.htm Edgar Link pending
exhibit321-ceocertificatio.htm Edgar Link pending
exhibit322-cfocertificatio.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
psix-20230630.htm Edgar Link pending
psix-20230630.xsd Edgar Link pending
psix-20230630_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
psix-20230630_cal.xml Edgar Link unprocessable
psix-20230630_def.xml Edgar Link unprocessable
psix-20230630_lab.xml Edgar Link unprocessable
psix-20230630_pre.xml Edgar Link unprocessable
psix-20230630_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending